Skip navigation

Ritesh Srivastava

General Counsel

Mr. Srivastava joins BPGbio from Spectrum Pharmaceuticals, a publicly traded biopharmaceutical company, where he held several leadership roles for over 5 years, including most recently as Global Compliance Officer. At Spectrum, Mr. Srivastava provided leadership and counsel in all legal and compliance matters in acquiring, developing, and commercializing novel and targeted drug products in hematology and oncology.  In 2023, he advised the company on its acquisition by a specialty pharmaceutical company.  Prior to its acquisition, he guided the company through multiple licensing deals and in the sale of the company’s portfolio of hematology/oncology drugs to a U.S. based biopharmaceutical company.  Mr. Srivastava also partnered with finance teams on public company filings and disclosures; guidance through proxy contests; and in capital raising activities.

Prior to that, Mr. Srivastava led investigations and regulatory compliance initiatives at Avanir Pharmaceuticals and also, served as a federal prosecutor with the United States Department of Justice, leading law enforcement teams in the investigation and prosecution of health care fraud and anti-kickback matters.

Early in his career, he was a private practice litigator working with pharmaceutical, biotechnology, and medical device companies, and was a member of the United States Navy JAG Corps for six years, most recently as Lieutenant Commander.

He received his bachelor’s degree in engineering from Columbia University and his Juris Doctor from Pepperdine University School of Law.